| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
vß3 in Angiogenesis In vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and
vß3 Are Critical
1 Department of Morphology, University Medical Center, Geneva, Switzerland; 2 Oncology Research and 3 Medicinal Chemistry, Merck KGaA, Darmstadt, Germany; 4 Centre for Blood Research, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada; 5 Celltech, Slough, Berkshire, United Kingdom; 6 School of Biological Sciences, University of East Anglia, Norwich, United Kingdom; and 7 NetCare Molecular Medicine Institute, Unitas Hospital, and Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Requests for reprints: Michael S. Pepper, NetCare Molecular Medicine Institute, Unitas Hospital, Clifton Avenue, 0140 Lyttleton, Pretoria, South Africa. Phone: 27-12-677-8504; Fax: 27-12-677-8505; E-mail: mpepper{at}doctors.netcare.co.za.
Matrix metalloproteinase (MMP)-2 and its hemopexin C domain autolytic fragment (also called PEX) have been proposed to be crucial for angiogenesis. Here, we have investigated the dependency of in vitro angiogenesis on MMP-mediated extracellular proteolysis and integrin
vß3mediated cell adhesion in a three-dimensional collagen I model. The hydroxamate-based synthetic inhibitors BB94, CT1399, and CT1847 inhibited endothelial cell invasion, as did neutralizing antimembrane-type 1-MMP (MT1-MMP) antibodies and tissue inhibitor of MMP (TIMP)-2 and TIMP-3 but not TIMP-1. This confirmed the pivotal importance of MT1-MMP over other MMPs in this model. Invasion was also inhibited by a nonpeptidic antagonist of integrin
vß3, EMD 361276. Although PEX strongly inhibited pro-MMP-2 activation, when contaminating lipopolysaccharide was neutralized, PEX neither affected angiogenesis nor bound integrin
vß3. Moreover, no specific binding of pro-MMP-2 to integrin
vß3 was found, whereas only one out of four independently prepared enzymatically active MMP-2 preparations could bind integrin
vß3, and this in a PEX-independent manner. Likewise, integrin
vß3expressing cells did not bind MMP-2-coated surfaces. Hence, these findings show that endothelial cell invasion of collagen I gels is MT1-MMP and
vß3- dependent but MMP-2 independent and does not support a role for PEX in
vß3 integrin binding or in modulating angiogenesis in this system.
This article has been cited by other articles:
![]() |
P. A. Rupp, R. P. Visconti, A. Czirok, D. A. Cheresh, and C. D. Little Matrix Metalloproteinase 2-Integrin {alpha}v{beta}3 Binding Is Required for Mesenchymal Cell Invasive Activity but Not Epithelial Locomotion: A Computational Time-Lapse Study Mol. Biol. Cell, December 1, 2008; 19(12): 5529 - 5540. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang, K. J. Bayless, and R. Kaunas Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2087 - H2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Agren and M. Werthen The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds International Journal of Lower Extremity Wounds, June 1, 2007; 6(2): 82 - 97. [Abstract] [PDF] |
||||
![]() |
H. Piccard, P. E. Van den Steen, and G. Opdenakker Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins J. Leukoc. Biol., April 1, 2007; 81(4): 870 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Morrison and C. M. Overall TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains J. Biol. Chem., September 8, 2006; 281(36): 26528 - 26539. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |